[73] Outcomes of patients with advanced clear-cell renal cell carcinoma treated by sunitinib as first-line therapy: A prospective observational study in real-world practice of the Academic Hospital of Oran, Algeria
Objective: To investigate the effectiveness of sunitinib as first-line therapy in real-world practice in terms of progression-free survival (PFS), objective response rate (ORR), and overall survival (OS), and to evaluate the safety profile for advanced or metastatic clear-cell renal cell carcinoma (...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Taylor & Francis Group
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5ecc5685575f4e83ab3b6de9d0f97b37 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|